The prognostic value of modified quantitative classification and expression of monoclonal antibodies against PCNA in laryngeal neoplasm (introduction)
Lukomski, M.; Józefowicz-Korczyńska, M.; Kobos, J.
Otolaryngologia Polska 49(Suppl 20): 87-92
1995
ISSN/ISBN: 0030-6657 PMID: 9454230 Document Number: 449318
In clinical practice there are no sufficient histopathological and immunohistochemical parameters to predicting progression of laryngeal cancer. We applied the new quantitative Anertoha, Blatsakisa and Luny cancer classification and expression of PCNA (proliferating cell nuclear antigen) to clinical findings to appreciate prognosis in laryngeal cancer.
Document emailed within 1 workday
Related Documents
Golusiński, W.; Szmeja, Z.; Olofsson, J.; Biczysko, W.; Krygier-Stojałowska, A.; Majewski, P. 1996: Diagnostic and prognostic value of p53 oncogene and the selected neoplastic markers (Ki67, PCNA, DNA ploidy) of the ultrastructure in patients with laryngeal cancer Otolaryngologia Polska 50(6): 607-617Rammeh-Rommani, S.; Zermani, R.; Sfaxi, M.; Chabchoub, A.; Zouari, B.éc.; Ayed, M.; Ben Jilani-Baltagi, S. 2007: Prognostic value of the immunohistochemical expression of: Ki67, p53, PCNA and Bcl2 in the superficial tumors of the bladder La Tunisie Medicale 85(6): 509-512
Budke, H.; Orazi, A.; Neiman, R.S.; Cattoretti, G.; John, K.; Barberis, M. 1994: Assessment of cell proliferation in paraffin sections of normal bone marrow by the monoclonal antibodies Ki-67 and PCNA Modern Pathology: An Official Journal of the United States and Canadian Academy of Pathology Inc 7(8): 860-866
Markiewski, M.; Domagała, W. 1996: Immunohistochemical assessment of proliferation rate of breast carcinoma cells using Ki-67, MIB-1 and anti-PCNA monoclonal antibodies Polish Journal of Pathology: Official Journal of the Polish Society of Pathologists 47(4): 189-194
Gómez Arbonés, X.; Campo Güerri, E.; Virgili, J.M.; Panades Siurana, M.J. 1995: Diagnostic and prognostic value of the immunohistochemical study of proliferating cell nuclear antigen (PCNA) expression in paraffin sections from non-hodgkin's lymphoma Sangre 40(6): 520-521
Rizvi, S.A. 2011: Monoclonal antibodies: an introduction Medicine and Health Rhode Island 94(11): 316
Boonyaphiphat, P.; Pruegsanusak, K.; Thongsuksai, P. 2012: The prognostic value of p53, Bcl-2 and Bax expression in laryngeal cancer Journal of the Medical Association of Thailand 95(10): 1317-1320
Groopman, J.D.; Haugen, A.; Goodrich, G.R.; Wogan, G.N.; Harris, C.C. 1982: Quantitation of aflatoxin B1-modified DNA using monoclonal antibodies Cancer Research 42(8): 3120-3124
Uchigata, Y.; Prabhakar, B.S.; Salata, K.F.; Ginsberg-Fellner, F.; Notkins, A.L. 1987: Human monoclonal multiple-organ-reactive autoantibodies distinguished by mouse monoclonal anti-idiotypic antibodies: expression of idiotopes in humans with and without autoimmune diseases Journal of Immunology 138(12): 4218-4221
Calli, C.; Calli, A.; Pinar, E.; Oncel, S.; Tatar, B. 2011: Prognostic significance of p63, p53 and ki67 expression in laryngeal basaloid squamous cell carcinomas B-Ent 7(1): 37-42
Gresíková, M.; Sekeyová, M. 1990: To the antigenic classification of some viruses from the tick-borne encephalitis complex by monoclonal antibodies Acta Virologica 34(1): 90-94
Agius, M.A.; Geannopoulos, C.J.; Fairclough, R.H.; Richman, D.P. 1988: Monoclonal anti-idiotopic antibodies against myasthenia-inducing anti-acetylcholine receptor monoclonal antibodies. Preponderance of nonparatope-directed antibodies affecting antigen binding Journal of Immunology 140(1): 62-68
Rasmussen, B.B.; Pedersen, B.V.; Thorpe, S.M.; Hilkens, J.; Hilgers, J.; Rose, C. 1985: Prognostic value of surface antigens in primary human breast carcinomas, detected by monoclonal antibodies Cancer Research 45(3): 1424-1427
Adamkiewicz, J.; Ahrens, O.; Huh, N.; Nehls, P.; Rajewsky, M.F.; Spiess, E. 1984: High-affinity monoclonal antibodies for the specific recognition and quantification of deoxynucleosides structurally modified by N-nitroso compounds Iarc Scientific Publications 57: 581-587
Horejsí, V.; Angelisová, P.; Bazil, V.; Kristofová, H.; Stoyanov, S.; Stefanová, I.; Hausner, P.; Vosecký, M.; Hilgert, I. 1988: Monoclonal antibodies against human leucocyte antigens. II. Antibodies against CD45 (T200), CD3 (T3), CD43, CD10 (CALLA), transferrin receptor (T9), a novel broadly expressed 18-kDa antigen (MEM-43) and a novel antigen of restricted expression (MEM-74) Folia Biologica 34(1): 23-34
Kuśnierczyk, P.; Wysocka, M.; Szkudlarek, J.; Steuden, I.; Szymaniec, S.; Kisielow, P. 1986: Quantitative analysis of tissue distribution of Ly10-like murine alloantigen(s) with antisera and monoclonal antibodies Archivum Immunologiae et Therapiae Experimentalis 34(4): 409-419
Iuronen, E.I.; Viĭksmaa, M.G.; Mikel'saar, A.V. 1988: The use of monoclonal antibodies for the quantitative determination of myoglobin by the solid phase immunoenzyme "sandwich" assay Voprosy Meditsinskoi Khimii 34(4): 132-136
Feng, Y.-M.; Li, X.-Q.; Sun, B.-C.; Gao, X.-C.; Gu, L.; Niu, Y.; Hao, X.-S. 2006: Prognostic molecular classification of breast cancers based on gene expression profiling Zhonghua Zhong Liu Za Zhi 28(12): 900-906
Mel'nikova, I.I.; Lunev, V.E.; Preĭgerzon, V.A.; Luneva, N.M.; Koshkin, S.A.; Rodionov, M.A.; Martsev, S.P. 1993: Monoclonal antibodies to human spleen ferritin. II. Localization of epitopes and quantitative parameters of antigen binding Biokhimiia 58(5): 759-771
Favrot, M.C.; Philip, I.; Philip, T.; Cabrillat, H.; Pinatel, C.; Doré, J.F.; Lenoir, G.M. 1985: Immunophenotypic classification of 28 Burkitt cell lines with monoclonal antibodies and reagent selection for bone-marrow purging Iarc Scientific Publications 1985(60): 447-452